Technical Support: menoci@medizin.uni-goettingen.de
Department of Medical Informatics
University Medical Center Göttingen
Imprint
View primary antibody
Basic data
| PID | primary-0794 |
| EPIC PID | https://hdl.handle.net/21.11124/primary-0794 |
| Research group | RG Zimmermann |
| Quality (mean) | no score (0.00) |
| Sharing level | Public |
Antibody data
| Antigen symbol | TUBB3 |
| Antibody Registry ID(s) | AB_2313773 |
| Name | Purified anti-Tubulin β 3 (TUBB3) Antibody |
| Alternative name | CFEOM3A |
| Lab ID | |
| Tag / Fluorophore | |
| Raised in | Mouse |
| Reacts with | human, mouse, rat |
| Clone | TUJ1 |
| Isotype | IgG2a, κ |
| Clonality | monoclonal |
| Demasking | unknown |
| Antigen | This antibody was raised against microtubules derived from rat brain. |
| Crafted By | company |
| Company / Manufacturer | Covance |
| Catalog no. | MMS-435P |
| Lot no. | |
| Description | Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 1.0 - 5.0 µg/ml is suggested. For Western blotting, the suggested use of this reagent is 1.0 - 5.0 µg/ml. For immunocytochemistry, a concentration range of 1.0 - 5.0 μg/ml is recommended. It is recommended that the reagent be titrated for optimal performance for each application. |
| Localization | |
| Storage instruction | The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody. |
| Receipt date | 2021-10-11 00:00:00 |
| Preparation date | 2021-10-11 00:00:00 |
| Created by | Klauenberg, Vanessa |
| Last modified | Klauenberg, Vanessa |
External links
Applications
No application comments yet.
Linked publications
Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression
Schoger E, Zimmermann W, Cyganek L, Zelarayán LC
Stem Cell Res 2021 : 10.1016/j.scr.2021.102473
Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation
Schoger E, Zimmermann W, Cyganek L, Zelarayán LC
Stem Cell Res 2021 : 10.1016/j.scr.2021.102518
Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation
Maurer W, Rebs S, Köhne S, Eberl H, Wollnik B, Zibat A, Streckfuss-Bömeke K
Stem Cell Res 2024 : 10.1016/j.scr.2024.103409
Genomic and biological panoramas of non-muscle actinopathies
Di Donato N, Thom A, Rump A, Greve JN, Kropp M, Cadiñanos J, Calabro S, Cathey S, Chung B, Cope H, Costales M, Cuvertino S, Dinkel P, Erripi K, Fry AE, Garavelli L, Guan K, Hoffjan S, Janzarik WG, Koenig M, Kreimer I, Kuenzel K, Mancini G, Marin-Reina P, Meinhardt A, Niehaus I, Pilz D, Ricca I, Simarro FS, Schrock E, Marquardt A, Taft MH, Tezcan K, Thunström S, Verhagen J, Verloes A, Wollnik B, Krawitz P, Hsieh T, Zeef L, Seifert M, Heide M, Lawrence CB, Roberts N, Manstein D, Woolf AS, Banka S
medRxiv 2024 : 10.1101/2024.08.21.24310320
The lincRNA Pantr1 is a FOXG1 target gene conferring site-specific chromatin binding of FOXG1
Gather F, Rauleac T, Akol I, Arumugam G, Fullio CL, Müller T, Kleidonas D, Fischer A, Vlachos A, Backofen R, Vogel T
bioRxiv 2024 : 10.1101/2024.08.29.610239
The lincRNA Pantr1 is a FOXG1 target gene conferring site-specific chromatin binding of FOXG1
Gather F, Rauleac T, Akol I, Arumugam G, Fullio C, Müller T, Kleidonas D, Geiss-Friedlander R, Fischer A, Vlachos A, Backofen R, Vogel T
Nucleic Acids Res 2025 : 10.1093/nar/gkaf539
